TY - JOUR
T1 - Retracted
T2 - Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566
AU - Deacon, R. M.J.
AU - Hurley, M. J.
AU - Rebolledo, C. M.
AU - Snape, M.
AU - Altimiras, F. J.
AU - Farías, L.
AU - Pino, M.
AU - Biekofsky, R.
AU - Glass, L.
AU - Cogram, P.
N1 - Publisher Copyright:
© 2017 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Retraction: "Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566" by R. M. J. Deacon, M. J. Hurley, C. M. Rebolledo, M. Snape, F. J. Altimiras, L. Farías, M. Pino, R. Biekofsky, L. Glass and P. Cogram. The above article, from Genes, Brain and Behavior, published online on 12th May 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor in Chief, Andrew Holmes and John Wiley & Sons Ltd. The retraction has been agreed as all authors cannot agree on a revised author order, and at least one author continues to dispute the original order. In this case, the original article is being retracted on the grounds that the journal does not have permission to publish. Reference: Deacon, R. M. J., Hurley, M. J., Rebolledo, C. M., Snape, M., Altimiras, F. J., Farías, L., Pino, M., Biekofsky, R., Glass, L. and Cogram, P. (2017), Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566. Genes, Brain and Behavior. doi:10.1111/gbb.12373.
AB - Retraction: "Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566" by R. M. J. Deacon, M. J. Hurley, C. M. Rebolledo, M. Snape, F. J. Altimiras, L. Farías, M. Pino, R. Biekofsky, L. Glass and P. Cogram. The above article, from Genes, Brain and Behavior, published online on 12th May 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor in Chief, Andrew Holmes and John Wiley & Sons Ltd. The retraction has been agreed as all authors cannot agree on a revised author order, and at least one author continues to dispute the original order. In this case, the original article is being retracted on the grounds that the journal does not have permission to publish. Reference: Deacon, R. M. J., Hurley, M. J., Rebolledo, C. M., Snape, M., Altimiras, F. J., Farías, L., Pino, M., Biekofsky, R., Glass, L. and Cogram, P. (2017), Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566. Genes, Brain and Behavior. doi:10.1111/gbb.12373.
UR - http://www.scopus.com/inward/record.url?scp=85018890081&partnerID=8YFLogxK
U2 - 10.1111/gbb.12373
DO - 10.1111/gbb.12373
M3 - Article
C2 - 28211606
AN - SCOPUS:85018890081
SN - 1601-183X
VL - 16
SP - 739
JO - Genes, brain, and behavior
JF - Genes, brain, and behavior
IS - 7
ER -